Impaired endothelial vasoregulatory function in patients with systemic lupus erythematosus: association with renal involvement, inflammatory markers, and autoantibodies

Authors

DOI:

https://doi.org/10.22141/2307-1257.9.1.2020.196912

Keywords:

systemic lupus erythematosus, endothelium, endothelium-dependent vasodilation, nephritis, autoantibodies

Abstract

Background. The leading cause of death in patients with systemic lupus erythematosus (SLE) is cardiovascular diseases due to early atherosclerosis. Endothelial dysfunction is considered one of the markers of subclinical atherosclerosis. The work aimed at assessing the endothelial vasoregulatory function in patients with SLE and its relationship with clinical and laboratory features of SLE. Materials and methods. We studied endothelium-dependent (EDVD) and endothelium-independent vasodilation (EIVD) of the brachial artery in 100 patients with SLE. Results. EDVD in patients with SLE was reduced by an average of 31.5 % compared with healthy individuals (p < 0.001). The average va­lues of EIVD in the group of patients with SLE (20.03 ± 0.80 %) and in the group of healthy individuals (21.4 ± 0.7 %) did not significantly differ (p > 0.05). The presence of lupus nephritis was associated with a significant deterioration in EDVD (42.5 % compared with the control group and 25.8 % compared with the alternative group, p < 0.001 and p < 0.05, respectively). The ave­rage values of EDVD in patients with elevated levels of C-reactive protein (CRP) were reduced by 35.1 % compared with the control group (p < 0.001), and in patients with normal levels of CRP — by 25.9 % (p < 0.001; the difference between the subgroups is unreliable). No significant correlation between the values of CRP and EDVD was found (r = 0.10, p > 0.05). In patients with positive antinuclear factor (ANF) and antibodies to native DNA (anti-nDNA), the values of EDVD were 32.0 and 35.2 % lower, respectively, than in the control group (p < 0.001). At the same time, in patients with negative ANF and anti-nDNA, the difference with the control group was unreliable (p > 0.05). According to the results of multiple linear regression analysis, the independent determinants of EDVD were the patient’s age (p < 0.001), the pre­sence of nephritis (regardless of its form) (p = 0.001), polyarthritis (p = 0.019), and Raynaud’s syndrome (p = 0.045). Conclusions. SLE patients have impaired vasoregulatory function of the endothelium, especially in the presence of lupus nephritis, elevated titers of ANF and anti-nDNA. EDVD does not correlate with CRP level in patients with SLE.

Downloads

Download data is not yet available.

References

Munteanu A, Caraba A, Romosan I. Endothelial dysfunction in lupus nephritis. Annals of the Romanian Society for Cell Biology. 2013;18(2):86-90.

Cavazzana I, Piantoni S, Sciatti E, et al. Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors. Lupus. 2019;28(2):210-216. doi: 10.1177/0961203318821161.

Yao G, Qi J, Zhang Z, al. Endothelial cell injury is involved in atherosclerosis and lupus symptoms in gld.apoE−/− mice. Int J Rheum Dis. 2018;22(3):488-496. doi: 10.1111/1756-185x.13458. 

Atehortúa L, Rojas M, Vásquez GM, Castaño D. Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction. Mediators Inflamm. 2017;2017:9680729. doi: 10.1155/2017/9680729.

Atehortúa L, Rojas M, Vásquez G, et al. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):34. doi: 10.1186/s13075-018-1796-4.

Mauro D, Nerviani A. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities. Rev Recent Clin Trials. 2018;13(3):192-198. doi: 10.2174/1574887113666180314091831.

Taraborelli M, Sciatti E, Bonadei I, et al. Endothelial Dysfunction in Early Systemic Lupus Erythematosus Patients and Controls Without Previous Cardiovascular Events. Arthritis Care Res (Hoboken). 2018;70(9):1277-1283. doi: 10.1002/acr.23495.

Mak A, Kow NY, Schwarz H, Gong L, Tay SH, Ling LH. Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression. Sci Rep. 2017;7(1):7320. doi: 10.1038/s41598-017-07574-1.

Nawata A, Hisano S, Shimajiri S, Wang KY, Tanaka Y, Nakayama T. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis. Histopathology. 2018;72(7):1084-1092. doi: 10.1111/his.13454.

Yuan M, Tan Y, Wang Y, Wang SX, Yu F, Zhao MH. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study. Lupus. 2019;28(3):347-358. doi: 10.1177/0961203319828509.

Deng W, Xu M, Meng Q, et al. CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury. Rheumatology (Oxford). 2019;58(11):2039-2050. doi: 10.1093/rheumatology/kez112.

Dimou P, Wright RD, Budge KL, et al. The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis. Sci Rep. 2019;9(1):8348. doi: 10.1038/s41598-019-44868-y.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.

Kovalenko VN, Shuba NM, Gajko GV, Dzjak GV, Korzh MO, Procenko GO, authors; Kovalenko VN, Shuba NM, editors. Nomenklatura, klasyfikacija, kryterii' diagnostyky ta programy likuvannja revmatychnyh hvorob [Nomenclature, classification, diagnostic criteria and treatment programs for rheumatic diseases]. Kyiv; 2004. 156 p. (in Ukrainian).

Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24(6):1468-1474. doi: 10.1016/0735-1097(94)90141-4.

Voronenko JuV, Moskalenko VO, Procek OT, et al, authors; Voronenko JuV, Moskalenko VF, editors. Social'na medycyna ta organizacija ohorony zdorov’ja [Social medicine and health care organization]. Ternopil: Ukrmedknyga; 2000. 670 p. (in Ukrainian).

Bühl J, Zöfel P. SPSS Version 10. Einführung in die moderne Datenanlyse unter Windows. 7th ed. Bonn, Deutschland: Addison Wesley; 2000. 734 p. (in German).

Caraba A, Savoiu G, Crisan V. Endothelial dysfunction in systemic lupus erythematosus. RJB. 2008;18(3):237-244.

El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation. 2004;110(4):399-404. doi: 10.1161/01.CIR.0000136807.78534.50.

Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002;29(2):292-297.

Piper MK, Raza K, Nuttall SL, et al. Impaired endothelial function in systemic lupus erythematosus. Lupus. 2007;16(2):84-88. doi: 10.1177/0961203306074842.

Falaschi F, Ravelli A, Martignoni A, et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2000;43(6):1405-1409. doi: 10.1002/1529-0131(200006)43:6<1405::AID-ANR26>3.0.CO;2-V.

Frostegård J, Svenungsson E, Wu R, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 2005;52(1):192-200. doi: 10.1002/art.20780.

Karadag O, Calguneri M, Atalar E, et al. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients. Clin Rheumatol. 2007;26(5):695-699. doi: 10.1007/s10067-006-0376-1.

Wright SA, O'Prey FM, Rea DJ, et al. Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol. 2006;26(10):2281-2287. doi: 10.1161/01.ATV.0000238351.82900.7f.

Published

2021-09-08

How to Cite

Matiyashchuk, I., Amosova, K., Iaremenko, O., Zakharova, V., & Koliadenko, D. (2021). Impaired endothelial vasoregulatory function in patients with systemic lupus erythematosus: association with renal involvement, inflammatory markers, and autoantibodies. KIDNEYS, 9(1), 14–19. https://doi.org/10.22141/2307-1257.9.1.2020.196912

Issue

Section

Original Articles